| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥891.9B | ¥872.8B | +2.2% |
| Operating Income | ¥94.3B | ¥59.9B | +57.3% |
| Profit Before Tax | ¥98.9B | ¥63.8B | +55.1% |
| Net Income | ¥71.7B | ¥42.8B | +67.7% |
| ROE | 8.1% | 5.2% | - |
FY2026 Q3 results: Revenue ¥891.9B (YoY +2.2%), Operating Income ¥94.3B (YoY +57.3%), Net Income ¥71.7B (YoY +67.7%). The company achieved significant profit growth despite modest revenue expansion. Operating margin improved to 10.6% from 6.9% in the prior year, driven by enhanced gross margin and controlled selling, general and administrative expenses. The company maintains a robust balance sheet with equity ratio of 70.7% and generated strong free cash flow of ¥103.8B. Short-term borrowings were reduced by 49.5% YoY to ¥27.0B, demonstrating improved financial flexibility. The company executed share buybacks totaling ¥20.4B while maintaining high cash reserves of ¥178.5B.
Revenue grew 2.2% YoY to ¥891.9B, reflecting moderate top-line expansion. Gross profit increased to ¥264.7B with gross margin improving to 29.7% from prior year levels, indicating enhanced cost management and product mix optimization. Operating expenses were well-controlled, contributing to the substantial operating profit increase of ¥34.3B. The operating profit improvement was driven by three primary factors: cost of sales reduction relative to revenue growth, disciplined overhead spending, and operational efficiency gains.
Operating income of ¥94.3B increased 57.3% YoY, significantly outpacing revenue growth. The operating margin expansion of 3.7 percentage points demonstrates meaningful operational leverage. Non-operating items contributed positively, with equity method investment gains of ¥7.4B and net financial income of ¥4.6B (financial income ¥7.2B less financial costs ¥2.6B), resulting in ordinary income exceeding operating income by ¥4.6B. Pre-tax income reached ¥98.9B, with an effective tax rate of 27.4%, leading to net income of ¥71.6B.
The company demonstrates a revenue up/profit up pattern with significant profit acceleration. The profit growth rate (67.7%) substantially exceeds revenue growth (2.2%), indicating strong operational improvement and margin expansion rather than volume-driven growth. This pattern reflects successful cost structure optimization and pricing power maintenance.
[Profitability] ROE of 8.1% shows improvement from prior levels and aligns with the company's 3-factor DuPont analysis of net profit margin 8.0%, asset turnover 0.710, and financial leverage 1.41. Operating margin reached 10.6%, expanding 3.7 percentage points YoY from 6.9%. Net profit margin improved to 8.0% from 4.9% in the prior year, reflecting enhanced profitability across the income statement. EBIT margin of 10.6% indicates solid operational performance, supported by tax burden coefficient of 0.724 and interest burden of 1.049. [Cash Quality] Cash and cash equivalents totaled ¥178.5B, providing strong liquidity coverage. Operating cash flow of ¥124.3B represents 1.74 times net income, confirming high-quality, cash-backed earnings. Free cash flow generation of ¥103.8B demonstrates robust cash conversion capabilities. [Investment Efficiency] Total asset turnover of 0.710 reflects moderate asset utilization. Capital expenditure of ¥32.5B represents controlled investment spending relative to operating cash flow. Days sales outstanding and days inventory outstanding show extended working capital cycles per quality indicators. [Financial Health] Equity ratio of 70.7% significantly exceeds typical manufacturing sector standards, indicating very strong financial stability. Debt-to-equity ratio of 0.41 and interest-bearing debt of ¥44.9B represent minimal leverage. The company reduced short-term borrowings by 49.5% YoY to ¥27.0B, improving near-term refinancing risk profile.
Operating cash flow of ¥124.3B represents 1.74 times net income, confirming strong cash generation quality with positive accrual reversal patterns. The operating CF improvement was supported by working capital movements including accounts payable increase of ¥16.9B, partially offset by accounts receivable increase of ¥13.7B and inventory increase of ¥1.3B. Investing cash flow of negative ¥20.5B was primarily driven by capital expenditures of ¥32.5B, acquisition of equity method investee shares of ¥2.0B, and intangible asset purchases of ¥1.8B. Free cash flow of ¥103.8B demonstrates substantial surplus cash generation after investment needs. Financing cash flow reflects active shareholder return activities with share repurchases of ¥20.4B executed during the period, while short-term debt repayment contributed to the ¥26.5B reduction in borrowings. The company's cash position of ¥178.5B provides comfortable coverage of near-term obligations and supports continued capital allocation flexibility.
Ordinary income of ¥94.3B aligns closely with operating income of ¥94.3B, with non-operating net contribution of approximately ¥4.6B comprising equity method investment gains of ¥7.4B and net financial income of ¥4.6B as primary components. Non-operating income represents 1.3% of revenue, consisting of interest and dividend income of ¥7.2B and financial costs of ¥2.6B, resulting in net positive financial position. The equity method investment contribution, while positive, decreased from prior year levels and warrants monitoring for sustainability. Operating cash flow of ¥124.3B exceeding net income of ¥71.6B by 74% indicates healthy earnings quality with strong cash realization. The accrual ratio of negative 4.2% suggests cash earnings exceeding accrual-based earnings, a positive quality indicator. No material non-recurring items such as impairment losses, asset sales, or restructuring charges were identified in the current period, indicating core operational earnings sustainability.
Working capital efficiency deterioration risk: Days sales outstanding and days inventory outstanding have extended beyond optimal levels, indicating potential cash cycle pressures. Current receivables of ¥250.1B and inventory of ¥206.6B represent substantial working capital deployment that could impact cash generation if collection or turnover velocity further declines.
Short-term liability structure concentration: Short-term liabilities represent 60.2% of total liabilities, creating potential refinancing risk despite strong overall equity position. While short-term borrowings decreased 49.5% to ¥27.0B, the high proportion of current liabilities warrants continued monitoring of maturity profiles and refinancing capabilities.
Equity method investment volatility: Equity method investment gains of ¥7.4B declined from prior year levels and represent meaningful non-operating income contribution. Performance variability in affiliated companies, exposed to separate market and operational risks, could materially impact consolidated earnings given the ¥4.6B ordinary income contribution from non-operating sources.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: Operating margin of 10.6% exceeds industry median of 8.7% (IQR: 5.1%-12.6%), positioning the company in the upper half of manufacturing sector peers. Net profit margin of 8.0% also surpasses industry median of 6.4% (IQR: 3.3%-9.3%), reflecting superior profitability conversion. ROE of 8.1% exceeds industry median of 5.2% (IQR: 3.0%-8.3%), indicating above-average equity utilization efficiency.
Financial Health: Equity ratio of 70.7% significantly exceeds industry median of 63.8% (IQR: 49.4%-74.5%), demonstrating exceptionally strong capital structure. The company maintains minimal leverage compared to sector peers, with net debt/EBITDA in negative territory indicating net cash position versus industry median of negative 1.11.
Efficiency: Revenue growth of 2.2% aligns with industry median of 2.8% (IQR: -1.7%-8.1%), showing in-line top-line performance. Asset turnover of 0.710 exceeds industry median of 0.58 (IQR: 0.41-0.66), reflecting superior asset productivity. However, working capital metrics show room for improvement, with receivables turnover and inventory turnover cycles extended relative to efficient peer practices.
Cash Generation: Cash conversion ratio of 1.74 (operating CF to net income) exceeds industry median of 1.17 (IQR: 0.66-2.24), confirming superior cash earnings quality. FCF yield positioning reflects strong cash generation relative to market valuation.
(Industry: Manufacturing, N=100 companies, Comparison: FY2025-Q3 benchmarks, Source: Proprietary analysis)
Significant operational leverage realized: The company achieved 57.3% operating profit growth on 2.2% revenue growth, demonstrating substantial margin expansion and operating leverage. The 3.7 percentage point improvement in operating margin to 10.6% reflects successful cost structure optimization and positions the company above industry median profitability levels. This margin improvement combined with 1.74x operating CF to net income conversion indicates high-quality, sustainable earnings improvement.
Fortress balance sheet with active capital deployment: Equity ratio of 70.7% and net cash position provide exceptional financial flexibility, significantly exceeding industry standards. The company actively utilized this strength through ¥20.4B in share repurchases while simultaneously reducing short-term debt by ¥26.5B and generating ¥103.8B in free cash flow. This combination of balance sheet strength, shareholder returns, and deleveraging demonstrates disciplined capital allocation, though the sustainability and scale of buyback programs warrant monitoring relative to operational investment needs.
Working capital efficiency represents key improvement opportunity: Extended receivables and inventory cycles, flagged in quality indicators, contrast with otherwise strong operational and financial performance. Days sales outstanding and inventory turnover metrics lag efficient industry practices, indicating meaningful opportunity for cash cycle improvement. Enhanced working capital management could further strengthen already-robust cash generation, providing additional capacity for growth investment or shareholder returns while maintaining the company's strong competitive position in profitability and financial stability.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.